AARD Iron Condor Strategy
AARD (Aardvark Therapeutics, Inc. Common Stock), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments. These therapies are designed to stimulate the body's natural regulatory systems (innate homeostatic pathways) to combat metabolic disorders. The company's primary experimental drug, ARD-101, is an orally administered, gut-specific small molecule. It functions as an agonist, targeting particular bitter taste receptors found within the gut lumen. ARD-101 is currently undergoing a Phase III clinical trial for managing excessive hunger (hyperphagia) associated with Prader-Willi Syndrome. Additionally, it is in a Phase II trial for addressing hyperphagia linked to acquired hypothalamic obesity, often a result of craniopharyngioma treatments like surgery or radiation therapy.
AARD (Aardvark Therapeutics, Inc. Common Stock) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $143.8M, a beta of 3.81 versus the broader market, a 52-week range of 3.35-17.94, average daily share volume of 238K, a public-listing history dating back to 2025, approximately 40 full-time employees. These structural characteristics shape how AARD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 3.81 indicates AARD has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a iron condor on AARD?
An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes.
AARD snapshot
As of August 14, 2026, spot at $6.53, ATM IV 191.70%, IV rank 38.20%, expected move 54.96%. The iron condor on AARD below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this iron condor structure on AARD specifically: AARD IV at 191.70% is mid-range versus its 1-year history, so the credit collected on a AARD iron condor sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 54.96% (roughly $3.59 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AARD expiries trade a higher absolute premium for lower per-day decay. Position sizing on AARD should anchor to the underlying notional of $6.53 per share and to the trader's directional view on AARD stock.
AARD iron condor setup
The AARD iron condor below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AARD at $6.53 on that close, the first option leg uses a $6.86 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AARD chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AARD shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Call | $6.86 | N/A |
| Buy 1 | Call | $7.18 | N/A |
| Sell 1 | Put | $6.20 | N/A |
| Buy 1 | Put | $5.88 | N/A |
AARD iron condor risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit.
AARD iron condor payoff curve
Modeled P&L at expiration across a range of underlying prices for the iron condor on AARD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use iron condor on AARD
Iron condors on AARD are a delta-neutral premium-collection structure that profits if AARD stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
AARD thesis for this iron condor
The market-implied 1-standard-deviation range for AARD extends from approximately $2.94 on the downside to $10.12 on the upside. A AARD iron condor is a delta-neutral premium-collection structure that pays off when AARD stays inside the inner short strikes through expiration; the wing width should reflect the trader's tolerance for the maximum loss scenario where the underlying breaches an outer strike. Current AARD IV rank near 38.20% is mid-range against its 1-year distribution, so the IV signal is neutral; the iron condor thesis on AARD should anchor more to the directional view and the expected-move geometry. As a Healthcare name, AARD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AARD-specific events.
AARD iron condor positions are structurally neutral / range-bound; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AARD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AARD alongside the broader basket even when AARD-specific fundamentals are unchanged. Short-premium structures like a iron condor on AARD carry tail risk when realized volatility exceeds the implied move; review historical AARD earnings reactions and macro stress periods before sizing. Always rebuild the position from current AARD chain quotes before placing a trade.
Frequently asked questions
- What is a iron condor on AARD?
- A iron condor on AARD is the iron condor strategy applied to AARD (stock). The strategy is structurally neutral / range-bound: An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes. With AARD stock at $6.53 on the most recent close, the strikes shown on this page are snapped to the nearest listed AARD chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are AARD iron condor max profit and max loss calculated?
- Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit. For the AARD iron condor priced from the end-of-day chain at a 30-day expiry (ATM IV 191.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a AARD iron condor?
- The breakeven for the AARD iron condor priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The AARD market-implied 1-standard-deviation expected move in the same options snapshot is approximately 54.96%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a iron condor on AARD?
- Iron condors on AARD are a delta-neutral premium-collection structure that profits if AARD stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
- How does current AARD implied volatility affect this iron condor?
- AARD ATM IV is at 191.70% with IV rank near 38.20%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.